Department of Pharmaceutical Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, MA 02115, USA.
Dicerna Pharmaceuticals, Lexington, MA 02421, USA.
Nanomedicine (Lond). 2021 Mar;16(7):535-551. doi: 10.2217/nnm-2020-0428. Epub 2021 Mar 8.
To evaluate the role of vitronectin-enriched protein corona on systemic delivery of siRNA-encapsulated cationic lipid nanoparticles (LNPs) to αvβ3 integrin expressing solid tumors. 1,2-Dioleoyl-3-trimethylammonium-propane LNPs were formulated, protein corona formed in nude mice serum and its impact on drug delivery were analyzed. 1,2-Dioleoyl-3-trimethylammonium-propane-containing LNP led to enhanced recruitment of vitronectin and showed preferential transfection to αvβ3-expressed cells relative to controls. Upon systemic administration in mice, the LNPs accumulated in the αvβ3-expressing endothelial lining of the tumor blood vessels before reaching tumor cells. These results present an optimized LNP that selectively recruits endogenous proteins to its corona which may lead to enhanced delivery and transfection in tissues of interest.
为了评估富含玻璃粘连蛋白的蛋白冠在将 RNA 干扰(siRNA)包裹于阳离子脂质体纳米颗粒(LNPs)系统递送至表达αvβ3 整合素的实体瘤中的作用。我们制备了 1,2-二油酰基-3-三甲铵丙烷(DOTAP)LNPs,分析了在裸鼠血清中形成的蛋白冠及其对药物传递的影响。含有 1,2-二油酰基-3-三甲铵丙烷的 LNPs 导致玻璃粘连蛋白的募集增加,并相对于对照显示出对表达αvβ3 的细胞的优先转染。在小鼠体内给药后,LNPs 在到达肿瘤细胞之前积聚在表达αvβ3 的肿瘤血管内皮衬里中。这些结果提出了一种经过优化的 LNPs,其选择性募集内源性蛋白到其蛋白冠,这可能导致在感兴趣的组织中增强递药和转染。